Background To explore and describe the current literature surrounding bacterial/fungal
coinfection in patients with coronavirus infection. Methods MEDLINE, EMBASE, and Web of …

Background Antibacterials may be initiated out of concern for bacterial coinfection in
coronavirus disease 2019 (COVID-19). We determined prevalence and predictors of empiric …

Objectives To investigate the incidence of bacterial and fungal coinfection of hospitalized
patients with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in …

Background: Coinfection with bacteria, fungi, and respiratory viruses in SARS-CoV-2 is of
particular importance due to the possibility of increased morbidity and mortality. In this meta …

Background To provide information about pathogens' coinfection prevalence with SARS‐
CoV‐2 could be a real help to save patients' lives. This study aims to evaluate the …

Objectives In previous influenza pandemics, bacterial co-infections have been a major
cause of mortality. We aimed to evaluate the burden of co-infections in patients with COVID …

Background: Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has affected millions of individuals since December …

Objectives The impact of bacterial/fungal infections on the morbidity and mortality of persons
with coronavirus disease 2019 (COVID-19) remains unclear. We have investigated the …

The novel coronavirus disease (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has placed an unprecedented strain on …

Background Patients hospitalized with coronavirus disease 2019 (COVID-19) are at
increased risk of health care–associated infections (HAIs), especially with prolonged …